Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Long-Term Investments: 2014-2018

Historic Long-Term Investments for Amicus Therapeutics (FOLD) over the last 1 years, with Jun 2018 value amounting to $13.8 million.

  • Amicus Therapeutics' Long-Term Investments was N/A to $13.8 million in Q2 2018 from the same period last year, while for Jun 2018 it was $13.8 million, marking a year-over-year change of. This contributed to the annual value of $17.5 million for FY2014, which is N/A change from last year.
  • According to the latest figures from Q2 2018, Amicus Therapeutics' Long-Term Investments is $13.8 million, which was down 67.58% from $42.7 million recorded in Q1 2018.
  • In the past 5 years, Amicus Therapeutics' Long-Term Investments registered a high of $42.7 million during Q1 2018, and its lowest value of $482,000 during Q2 2015.
  • Over the past 2 years, Amicus Therapeutics' median Long-Term Investments value was $15.1 million (recorded in 2017), while the average stood at $23.9 million.